BridgeMD
New treatment option for Smoking
Official title Evaluation of Lung Cancer CT Screening Performance Among Former and Current Smokers
ClinicalTrials.gov ID: NCT05486455
What this study is testing
- What it's testing
- Diagnostic performance of low-dose chest CT scan combined with lung-RADS classification (version 1.1) for lung cancer screening among former and current smokers.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 50 to 80
You may be able to join if
- Male or female 50-80 years old
- Active smoker (≥ 15 PA) or former smoker (≥ 15 PA)
You likely can't join if
- Recent history of chest CT scan (within 12 months)
- Person unable to climb 2 floors
- Weight \> 140kg
- Personal history of cancer \< 5 years (currently being monitored by thoracic imaging)
The study team makes the final eligibility decision.
Where it's taking place
- Marseille, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 50 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Marseille, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.